Sanjay Gandhi to Dopamine Agents
This is a "connection" page, showing publications Sanjay Gandhi has written about Dopamine Agents.
Connection Strength
0.141
-
McGarry A, Kieburtz K, Abler V, Grachev ID, Gandhi S, Auinger P, Papapetropoulos S, Hayden M. Safety and Exploratory Efficacy at 36 Months in Open-HART, an Open-Label Extension Study of Pridopidine in Huntington's Disease. J Huntingtons Dis. 2017; 6(3):189-199.
Score: 0.141